Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 867.3K | 388.8K | 556.7K | 414.0K |
| Selling general and admin | 865.3K | 866.2K | 1.7M | 451.2K |
| Other operating expenses | -57.5K | -278.6K | -14.3K | -109.7K |
| Operating income | -1.7M | -976.9K | -2.3M | -755.9K |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 51.4K | 63.7K | 62.3K | 58.7K |
| Other income expense | -125.1K | -121.1K | -64.0K | -199.7K |
| Pretax income | -1.9M | -1.2M | -2.4M | -1.0M |
| Tax provision | — | — | — | — |
| Net income | -1.9M | -1.2M | -2.4M | -1.0M |
| Basic EPS | 0 | 0 | — | 0.0 |
| Diluted EPS | 0 | 0 | — | 0.0 |
| Basic average shares | 420.3M | 420.3M | — | 419.9M |
| Diluted average shares | 420.3M | 420.3M | — | 419.9M |
| EBITDA | -1.7M | -976.4K | -2.3M | -753.7K |
| Net income from continuing op. | -1.9M | -1.2M | -2.4M | -1.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |